contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


aqua-bio-technology-asa-hydrafacial-has-entered-into-partnership-with-restorsea-conversion-lab-launches-veritas-md-platform

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Aqua Bio Technology is a Norwegian company operating in the cosmetics industry. The company develops, manufactures and commercializes ingredients that are used in various cosmetic products worldwide. The largest business is in solutions for skin care products. Most of the company's products are sold on a global market through various distributors. The company was founded in 2004 and has its headquarters in Lysaker.

Aqua Bio Technology

Restorsea's commercialization of Aqua Bio Technologies ASA's hatching fluid ingredient (Aquabeautine XL) continues.As mentioned in the commercial update on November 26, 2020, Restorsea has recently...

Restorsea's commercialization of Aqua Bio Technologies ASA's hatching fluid ingredient (Aquabeautine XL) continues.As mentioned in the commercial update on November 26, 2020, Restorsea has recently entered into two license agreements with two partners in addition to the license agreement with NASDAQ-listed Conversion Labs.In connection with Hydrafacial`s merger with Vesper Healthcare and the contemplated listing on <a href="https://www.globenewswire.com/Tracker?data=vn9W491l-RvSupKus276QJRvuPo3RdunND-2BVKsmNzjXXd2KjsnTdTl1rYORkjdh7tzMrgq2dq4FMonjXSbB-rSuHCYP2hiEPur3WLln41AffW5Dm7fM7vmPfh_qGLbIYs9EojPw9tSHLidyFHLk23ZmoiARWmdtPvM2MpCT-OCOEQQC3teRQl9Y66IfmSd5P0ke2V-FWo0CaS7fsyMHX99w35FkzNwjQBWhHXxiK-WzV7KArCggcv1uuEtunZ3Ttd9k8o3eBoVU8_EDNFSDQ==">NASDAQ Capital Market</a> (NASDAQ), Restorsea is presented as <a href="https://www.globenewswire.com/Tracker?data=tBlq6B0ARqiaBhGX8Maf8qGJBX5CuajoPHR2Rt1A6DZyy6OMYn0FHXYidvn8W-TIo_9OW3V69q448b5OJVf3g1kJU8hrX9jbIht0HvzSu5USZYR5ei81l9Bo903jvynnrPpoR7n4jBAktr3SkXAhytXhjMwIrpltXmOPEOPJmgiJVpWCtl2y-i07rD7pqxhjOyyRbjplbDeuUt1LGGYdGZF0dGcUHkxh_HYauAOZh4zUVbho-1zNejZpyMBQtTBv">Hydrafacial's new partner from 2021</a>. In Q3 2020, Hydrafacial has 15,124 skincare machines in 87 countries.As mentioned in <a href="https://www.globenewswire.com/Tracker?data=JeIvYryKKE-CO8Z0ZDrJHpivsQW_R6ujP0QkqSEt2iCaXSxMvI0evw5w7aRMfHKdSiQThAkc5js3ZCHZUmZ9AmiVyKY7HZiOnRyQi4aRz8_ybbjYF5viLsTsWdC8D9Mi8v21q131VMr9-o-EWwBpNQVvXZI1-eSXRfmlHdUIruyHWcur_ptVBL4oAtMNIw4qG2wXh4Mvrr9vutgafHBehnFeZfUaz6AQID3GZQZXwwQ=">the stock exchange announcement on 27 October 2020</a>, Restorsea has entered into an agreement to license Aquabeautine XL to the company Conversion Labs, which was listed on NASDAQ on 10 December 2020. Conversion Lab has today officially launched its new Veritas MD telecommunications health platform, which will roll out the new skincare brand Nava MD nationwide. Nava MD is based on Aquabeautine XL.The positive trend from Restorsea's commercialization of ABT's proprietary technology increases the likelihood that ABT will receive additional renewal payment and increased revenue from the sale of ingredients and royalties from Restorsea and its licensees.For further information, please contact Espen Kvale, CEO, telephone +47 916 28 092Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users.  ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the company's strategy going forward. Aqua Bio Technology is listed on Euronext Expand. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.<img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMDQ0NTM3NSM0MDA4MzY3NzkjMjAwMjk0Ng==" width="1" height="1"/> <img src="https://ml-eu.globenewswire.com/release/track/2e4dcd05-5354-46d2-bff2-2c29d752e817" width="1" height="1"/>

Aqua Bio Technology ASA: Hydrafacial has entered into partnership with Restorsea - Conversion Lab launches Veritas MD platform